Company / EPS (Diluted)
Cyclerion Therapeutics, Inc. EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.21
FY2025
5-year range
-$20.28 / -$1.21
FY2021-FY2025
Trend
+46.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 7 years, ranging from $-20.28 in FY2023 to $-1.21 in FY2025.
Based on SEC 10-K filings.
-1.21 in FY2025.
Improved from $-20.28 to $-1.21 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 46.2% year-over-year.
- Lowest eps (diluted) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.21 | +46.2% |
| FY2024 | -$2.25 | +88.9% |
| FY2023 | -$20.28 | -1436.4% |
| FY2022 | -$1.32 | +48.4% |
| FY2021 | -$2.56 | +43.0% |
| FY2020 | -$4.49 | -6.7% |
| FY2019 | -$4.21 | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026